Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2026; 32(29): 118233
Published online Aug 7, 2026. doi: 10.3748/wjg.118233
Published online Aug 7, 2026. doi: 10.3748/wjg.118233
Letter to the Editor: Decoding intrahepatic cholangiocarcinoma through lactate metabolism - from cellular states to therapeutic targets
Yasser Fouad, Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Minia University, Minia 19111, Egypt
Ahmed Gomaa, Department of Gastroenterology and Endemic Medicine, Fayoum University, Fayoum 19777, Egypt
Gamal Esmat, Department of Endemic Medicine and Hepatogastroenterology, Cairo University, Cairo 11562, Egypt
Gamal Esmat, Department of Research, Badr University, Cairo 12342, Egypt
Author contributions: Fouad Y conceptualised the idea; Fouad Y, Gomaa A, and Esmat G wrote and revised the manuscript.
Conflict-of-interest statement: All authors declared no conflict of interest.
Corresponding author: Yasser Fouad, MD, Professor, Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Minia University, El-Horria Street, Minia 19111, Egypt. yasser.abdallah@mu.edu.eg
Received: December 30, 2025
Revised: February 5, 2026
Accepted: February 12, 2026
Published online: August 7, 2026
Processing time: 202 Days and 13.7 Hours
Revised: February 5, 2026
Accepted: February 12, 2026
Published online: August 7, 2026
Processing time: 202 Days and 13.7 Hours
Core Tip
Core Tip: Lactate metabolism organises intrahepatic cholangiocarcinoma heterogeneity, linking metabolic activity to cellular hierarchy, mitochondrial function, and immune evasion, offering new avenues for stratification and therapy.